Specialty, Generics
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
96
NCT04612283
NGA-01 Gel for the Treatment of Osteoarthritis With Joint Pain
Phase: Phase 2/3
Role: Collaborator
Start: Oct 31, 2020
Completion: Jan 25, 2022
NCT05799651
Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 28, 2023
Completion: Dec 31, 2024
Loading map...